INTRODUCTION
Multipotent hematopoietic stem cells (HSCs) ensure sustained production of lineage committed blood cells throughout life. The pool of long-lived HSCs is preserved due to their inherent capacity to undergo self-renewal divisions. Cell fate decisions result from integrated influences of various nuclear factors, including chromatin modifiers that regulate access of transcriptional machinery to specified genomic loci. Chromatin, consisting of intertwined DNA, histone and non-histone proteins, can be covalently modified by epigenetic effectors.
DNA methyltransferases (DNMTs) modify carbon-5 of cytosine bases within cytosineguanosine dinucleotides (CpG) frequently located proximal to or in promoters 1 . In mammalian cells, the mechanism and effectors of DNA demethylation are less well understood, but recent reports suggest this process likely requires the activity of the TET enzyme family 2, 3 . Post-translational modifications of histones include methylation, acetylation, phosphorylation, ubiquitination, sumoylation or ADP-ribosylation (reviewed in 4 ) and introduce changes in local chromatin topography that subsequently alter gene expression patterns in developmental stage and cell context-specific manners.
Methylation of histone residues represents a classical paradigm linking epigenetics to cell fate and identity, best illustrated by the antagonistic forces of Polycomb (PcG) and Trithorax For personal use only. at SWETS INFORMATION SERVICES on August 21, 2013. bloodjournal.hematologylibrary.org From on histone H3 (H3K4me3) at transcription start sites, a mark associated with active gene transcription 6 and recruitment of H3K27me3 demethylases UTX and JMJD3 [7] [8] [9] . Additional
Trx-mediated modifications such as acetylation of H3K27 (H3K27Ac) and di-methylation of H3K36 (H3K36me2) further oppose the PcG mediated gene repression.
Histone methylation status on lysine (K) or arginine (R) residues is reported to evolve through highly dynamic and finely regulated processes (reviewed in 10 ). Histone demethylases (HDMs) integrate into multi-unit complexes resulting in removal of methylation marks by amine oxidation, deimination 11 or hydroxylation. The lysine specific demethylase 1 (LSD1/KDM1A)-related HDM can demethylate mono-and di-methylated lysine residues.
Jumonji C (JmjC) domain-containing HDMs (n=27) are capable of removing all three lysine methylation states by an oxidative reaction requiring α -ketoglutarate and iron (Fe 2+ ) as cofactors. Like the LSD1 family, JmjC/JARID1 proteins act as components of multi-subunit complexes, with non-catalytic domains proposed to mediate protein-protein interactions involved in regulation of demethylase activity and/or target specificity (reviewed in 12 ). In addition, JMJD6 demethylates arginine residues 13 , and bacterial Jumonji domain-containing AlkB protein is involved in DNA demethylation and repair 14, 15 suggesting that JmjC substrates include non-histone targets.
JmjC protein activity results in dynamic chromatin landscape changes which enable expression of distinct gene subsets required for self-renewal 16 , proliferation 17 , differentiation [18] [19] [20] , cellular senescence 21 and cancer development [22] [23] [24] . In light of these findings, an established in vivo RNAi based screening strategy 25 was undertaken, in a targeted way, to assess the impact of JmjC gene down-regulation on adult primary HSC cell fate. We identify Jarid1b as a negative regulator of HSC self-renewal and progenitor cell activity, while Jhdm1f positively influences blood reconstitution. Results from these experiments and possible downstream functional networks involved are presented. 26 and contribution of these cells to reconstitution of hematopoietic lineages 25, 26 were determined as described.
HSC/progenitor cell culture, retroviral infection and transplantation
Suspension cell cultures of HSC/progenitor cell enriched populations, generation of retrovirus-producing GP+E-86 cells and infection of the sorted HSC/progenitor cells were performed as described 26 . For validation assays, 1500 CD150 + CD48 -Lin -bone marrow derived cells were introduced in co-culture with retroviral producers in 96-well plates 26 . After 5-day incubation (day 0), the total cell content of each well was harvested, and partitioned for transplantation and cell culture as previously reported 25 . Briefly, 1/8 of cell suspension was transplanted into sublethally irradiated congenic recipients (n=2 for each shRNA species).
The remaining cells were cultured for additional 7 days and proportions corresponding to 1/8 of the cell input transplanted in 3 recipient mice (day 7). To compensate for the shJhdm1f-associated loss of reconstituting activity, ¼ of day 0 cell suspensions was transplanted in each of the 3 recipients, and no continuing suspension cultures were initiated.
Clonogenic progenitor cell assays
The total numbers and distributions of myeloid clonogenic progenitors in various cell populations recovered from the 5-day co-culture with retroviral producers (day 0), or from the subsequent suspension cultures (day 5-7) were determined as described 25 .
Microphotograpy
Images of Wright-stained cytospin cell preparations were acquired using a Leica DMIRB microscope with an HCXPL FluotarL 40×/0.6 numeric aperture objective (Leica) and a Retiga EX-i camera (Q-Imaging). Images were transformed directly into TIFF files using Adobe Photoshop Version 6.0 (Adobe Systems). In situ images of colonies in semisolid media were acquired using the same set up, but using the HC Pl Fluotar 10X/0.30, Ph 1 lens.
Competitive repopulating unit (CRU) assay
These assays were performed as previously described 25, 26 .
Q-RT-PCR assessment of JmjC gene expression in HSC enriched populations
Gene expression was assessed by Q-RT-PCR using the Roche LightCycler ® 480 System (Roche, Basel, Switzerland). Reactions were performed in 384-well plates for 50 amplification cycles (95°C 10 s; 60°C 10 s; 72°C 10 s). Reference Taqman ® gene assay (Hprt) was purchased from Applied Biosystems. Primer sequences in Table S2 , Delta Ct values in Table S3 .
ChIP-chip analysis
Two-colour hybridizations on NimbleGen MM8 Deluxe Promoter HX1 arrays were carried out using 34μg of Cy5-labeled input and 34μg of Cy3-labeled test (shLuc or shJarid1b) ChIP DNA using the NimbleGen hybridization kit as recommended by the manufacturer. Arrays were scanned at 5 μ m resolution using a GenePix4000B scanner (Molecular Devices). Data extraction and peak finding analysis was done using NimbleScan 2.5 and visualized in the UCSC genome browser.
RNA sequencing analysis
RNA sequencing was performed as previously described 27 . RNA was extracted from 1x 10 
Statistical Analysis
Statistical analysis was conducted using Prism (Graphpad Software version 5) or SPSS. The two-tailed Student-t-test was performed throughout unless otherwise stated. Statistical significance was calculated at a 95% confidence level. 
RESULTS

JmjC gene expression in HSC-enriched populations
Expression profiles were obtained for all JmjC genes in sorted mouse bone marrow and fetal liver cell populations comprising ≥ 30% of functionally defined long-term-repopulating LTRHSCs, as evaluated by competitive repopulation unit (CRU) assays 28 (Table S1) . Results
showed that all JmjC gene transcripts, except Hairless, were detected at relatively high levels (Fig. 1A) . The histone acetyl-transferase MOZ (MYST3), reported as essential for HSC expansion 29, 30 was also highly expressed in this fraction and chosen as a control for the functional screen. Transcript levels of four JmjC genes, namely Jarid1b, Jmjd2d, Fbxl10 and Jmjd1c, were notably increased in the LTR-HSC-enriched fractions relative to total bone marrow cells (Fig. 1B) . In contrast, Jhdm1d, Hspbap1 and Hairless transcript levels were notably higher in more mature cells. Genes expressed higher in the LTR-HSC enriched population e.g. Jarid1b, Jmjd2d, Fbxl10 and Jmjd1c were assigned a HSC expression score of one, while genes that were higher expressed in mature cells were attributed negative scores (Fig. 1B, lower panel) . Increased expression in LTR-HSCs implied a HSC biological role, and these candidates were prioritized in the functional studies.
Functional in vivo RNAi-based primary screen
The shRNA based screen tested 23 of the 27 known JmjC mouse genes ( Fig. 1C) for their potential functional role in HSC biology. shRNA Luciferase (shLuc) was used as a negative control, while shRNA Moz (shMoz) and Nup98Hoxa10-homeodomain (NA10hd) overexpression were used as controls for the loss and gain of HSC activity, respectively (data not shown for NA10hd, and 31,32 ). HDM-directed shRNA sequences (n=112 , Table S5 ) were subcloned into a LMP retroviral vector and assessed for their ability to modulate HSC/progenitor activity in vivo as previously reported 25 (summarized in Fig. 1D ). The To prioritize candidates for validation and downstream functional studies, a "selection threshold scoring system (STS)," weighted for HSC-enriched genes, was established ( Fig. 2A and Table S3 also Table S4 for complete data), and thus transduced cell expansion or attrition could be measured. Overall, six hits were identified: Jmjd2a, Jhdm1f
and Jmjd1b (STS of 2); Jarid1a, Jarid1b and Hif1an (STS of 3). Four of these genes; namely Jarid1a, Jarid1b, Jmjd2a, Hif1an, were identified as potential negative regulators of HSC activity ( 
Jarid1b knockdown decreases hematopoietic cell differentiation in vitro
Sh2-or sh3Jarid1b-transduced primitive hematopoietic cell populations had a ~1.5-2-fold proliferative advantage in vitro compared to shLuc controls, while Moz knockdown decreased expansion of the transduced cells (Fig. 4A, left panel) . The expanded shJarid1b-transduced populations comprised high proportions of morphologically immature cells (Fig. 4A, right panel), and lower percentages of differentiated (Gr1 + ) myeloid cells than shLuc controls (Fig.   4B ). Moreover, fractions of primitive (Gr1 -) shJarid1b-transduced cells were comparable to that determined in response to NA10hd, a well characterized enhancer of in vitro HSC/progenitor cell expansion, while a marked elevation in differentiation was observed for shMoz loss-of-function control (Fig. 4B ). During the 7-day culture period, the numbers of shJarid1b-transduced clonogenic progenitor cells (colony forming cell, CFC) increased ~3-fold compared to shLuc and shMoz controls (Fig.4C) . Jarid1b knockdown enhanced the proliferative capacity of individual CFCs compared to shMoz controls (Fig.4D) , and promoted expansion of the highly proliferative granulocyte-macrophage progenitors (Fig.   4E ). Although the total CFC contents of shLuc and shMoz control cultures were comparable (Fig. 4C) , and both cell populations differentiated into granulocytes and macrophages ( Fig.   4E ), the antiproliferative effect of Moz knockdown was evident from the decrease in sizes of shMoz clones compared to shLuc controls (data not shown). Moz expression enforced commitment to differentiation and senescence cell fate pathways.
Jarid1b negatively regulates HSC self-renewal
Transplant recipients of shJarid1b-cells had normal numbers of total bone marrow mononuclear cells (MNC), and no splenomegaly was observed (Fig. 5A, 1 st and 2 nd panels). Hoxa gene (Hoxa5 to Hoxa11) expression levels compared to controls ( Fig. 6A and Figure   S2 ). RNAseq analysis identified upregulation of genes associated with key pathways such as erythroid differentiation, notch signalling and stem/progenitor cell function ( Fig.6B and Figure S3 ), and downregulation of others involved in immune responses and differentiation ( Fig. 6C and Figure S4 ). Several of the candidate downstream genes, including Hoxa7, Hes1, Hoxa10 and Hoxb2, were identified as potential direct epigenetic targets by enrichment of the associated H3K4me3 mark in 5' loci as determined by ChIP-Chip assays ( Fig. 6D and Figure   S5 ). Supporting this possibility, non-regulated genes e.g. Hoxa2 demonstrated no proximal promoter H3K4me3 enrichment following Jarid1b knockdown ( Figure S5 ). Jarid1b knockdown also correlated with downregulation of the previously reported putative JARID1
target Cav1 34 (Table S7) .
For The proportions of mature GR1 + F4/80 + cell fractions in each condition were evaluated as a measure of differentiation (Fig. 6E, upper panel) . Results demonstrate that the combined effects of NA10hd overexpression and Jarid1b knockdown were additive, resulting in significant suppression of in vitro differentiation (p<0.0001; Student t-test) below the levels determined for control NA10hd+shLuc-cells (Fig. 6E, lower panel) . In contrast, shMoz targeted knockdown overrode the maturation arrest imposed by NA10hd overexpression, and enforced differentiation above the levels determined for controls (Fig. 6E, lower panel) .
Study of epistasis between
Together, the data presented support a role for Jarid1b in regulating key loci implicated in HSC cell fate and identify Jarid1b as a negative regulator of in vitro HSC expansion.
DISCUSSION
Following the established pipeline strategy from HSC isolation and infection to in vivo
functional assessment of hematopoietic reconstitution, the presented RNAi screen highlighted This observation supports the hypothesis that low Jarid1b levels maintain stem cell fate, which combined with BCR-ABL induced proliferation, could result in development of overt leukemia. In our studies, transplant recipients of shJarid1b-transduced cells never developed leukemia. However, all Jarid1b hairpins tested achieved similar gene knockdown (≤50%), and more drastic outcomes following complete Jarid1b depletion cannot be ruled out. Two Jarid1b null alleles, one (exon 1 deletion) embryonic lethal 41 the other (exon 6 deletion) no gross abnormalities, 20 have recently been described. Precise elucidation of the role Jarid1b gene dosage plays in HSCs and leukemia development will thus likely require analyses of HSC-specific Jarid1b deletion.
Overall, the data presented supports a cellular and developmental stage specific effect of Jarid1b levels in modulation of HSC cell fate. To sustain stem cell fate, integrated influences from various epigenetic effectors promote an active state of transcription at multipotency loci ( Fig.7 upper panel) . Activity of chromatin modifiers, including JARID1B, should culminate in maintenance of the H3K4me3 epigenetic mark on these loci, and exclusion of repressive marks, such as H3K9me3 or H3K27me3. Jhdm1f/PHF8 has recently been identified as a key regulator of ATRA response in acute promyelocytic leukemia cells 43 . Whether JHDM1F (Fig. 7, lower panel) . Other JmjC candidates (e.g. Hif1an) may also be involved in this process, underscoring the importance of further characterization of these enzymes in the context of HSC regulation. S.C., G.S., J.K. and A.T. wrote the paper.
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